Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
$564M |
| 2 |
UnitedHealth
UNH
|
$439M |
| 3 |
Johnson & Johnson
JNJ
|
$353M |
| 4 |
Amazon
AMZN
|
$200M |
| 5 |
Microsoft
MSFT
|
$198M |
Top Sells
| 1 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$344M |
| 2 |
JPMorgan Chase
JPM
|
$293M |
| 3 |
Kellanova
K
|
$165M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
$156M |
Sector Composition
| 1 | Technology | 18.85% |
| 2 | Financials | 18.69% |
| 3 | Industrials | 11.95% |
| 4 | Healthcare | 10.42% |
| 5 | Consumer Discretionary | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Broadway Financial
BYFC
$71.3M
| $164K | ﹤0.01% |
22,920
+1,361
| +6% | +$9.76K |
|
3152
Star Bulk Carriers
SBLK
$2.21B
| $158K | ﹤0.01% |
10,173
| – | – |
|
3153
Kezar Life Sciences
KZR
$29.8M
| $158K | ﹤0.01% |
32,310
| – | – |
|
3154
Larimar Therapeutics
LRMR
$337M
| $156K | ﹤0.01% |
72,649
-8,501
| -10% | -$18.3K |
|
3155
Inotiv
NOTV
$56.3M
| $155K | ﹤0.01% |
70,173
+38,547
| +122% | +$85.1K |
|
3156
Lightpath Technologies
LPTH
$243M
| $155K | ﹤0.01% |
77,050
+22,507
| +41% | +$45.2K |
|
3157
SR Bancorp
SRBK
$123M
| $155K | ﹤0.01% |
+12,945
| New | +$155K |
|
3158
Pitney Bowes
PBI
$2.11B
| $152K | ﹤0.01% |
16,833
-85,376
| -84% | -$773K |
|
3159
Taitron Components
TAIT
$12.8M
| $151K | ﹤0.01% |
59,843
+4,318
| +8% | +$10.9K |
|
3160
Coffee Holding Co
JVA
$23.7M
| $149K | ﹤0.01% |
41,993
+9,730
| +30% | +$34.5K |
|
|
CMLS
3161
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $141K | ﹤0.01% |
319,574
-134,632
| -30% | -$59.5K |
|
3162
US Global Investors
GROW
$31.8M
| $140K | ﹤0.01% |
61,944
| – | – |
|
3163
Lee Enterprises
LEE
$25.6M
| $139K | ﹤0.01% |
13,402
-18,256
| -58% | -$189K |
|
3164
CureVac
CVAC
$1.21B
| $138K | ﹤0.01% |
+49,607
| New | +$138K |
|
3165
PMV Pharmaceuticals
PMVP
$77.4M
| $137K | ﹤0.01% |
126,004
| – | – |
|
3166
Apyx Medical
APYX
$74.1M
| $136K | ﹤0.01% |
99,300
-8,982
| -8% | -$12.3K |
|
3167
Purple Innovation
PRPL
$122M
| $134K | ﹤0.01% |
177,022
| – | – |
|
3168
Sera Prognostics
SERA
$127M
| $134K | ﹤0.01% |
36,429
-3,276
| -8% | -$12K |
|
3169
Ironwood Pharmaceuticals
IRWD
$188M
| $133K | ﹤0.01% |
90,401
-128,021
| -59% | -$188K |
|
3170
Lantern Pharma
LTRN
$46.5M
| $133K | ﹤0.01% |
37,483
+934
| +3% | +$3.31K |
|
|
QVCGA
3171
QVC Group, Inc. Series A Common Stock
QVCGA
$73.3M
| $133K | ﹤0.01% |
13,212
-211
| -2% | -$2.12K |
|
3172
Dyne Therapeutics
DYN
$2.02B
| $131K | ﹤0.01% |
12,569
-87,009
| -87% | -$910K |
|
3173
Skillz
SKLZ
$114M
| $130K | ﹤0.01% |
28,823
| – | – |
|
3174
CuriosityStream
CURI
$265M
| $129K | ﹤0.01% |
+48,063
| New | +$129K |
|
3175
Lightbridge
LTBR
$369M
| $127K | ﹤0.01% |
17,024
-2,014
| -11% | -$15K |
|